|
Ampio Pharmaceuticals, Inc. (AMPE) DCF -Bewertung
US | Healthcare | Biotechnology | AMEX
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Ampio Pharmaceuticals, Inc. (AMPE) Bundle
Entdecken Sie den tatsächlichen Wert von Ampio Pharmaceuticals, Inc. (AMPE) mit unserem DCF-Taschenrechner von Professional Grade! Passen Sie die wichtigsten Annahmen an, erkunden Sie verschiedene Szenarien und bewerten Sie, wie sich Änderungen auf die Bewertung von Ampio auswirken - alles innerhalb einer einzigen Excel -Vorlage.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -17.3 | .0 | .0 | -18.3 | .0 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | 1.3 | 1.2 | 1.1 | 2.1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -18.6 | -1.2 | -1.1 | -20.4 | -.1 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 6.5 | 17.3 | 33.9 | 12.7 | 4.1 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .2 | .0 | .0 | .9 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .3 | 1.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .2 | .2 | .4 | .1 | .8 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -.1 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -11.8 | -1.2 | -.8 | -10.6 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -10.4 | -.5 | -.3 | -7.6 | -.3 | .2 | .0 | .0 | .0 | .0 |
| WACC, % | 2.6 | 4.06 | 2.98 | 2.12 | 4.06 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | 4 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | 4.91 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios tailored to Ampio Pharmaceuticals, Inc. (AMPE).
- Real-World Data: Ampio’s financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value specifically for Ampio Pharmaceuticals, Inc. (AMPE).
- Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as trial success rates, market penetration, and pricing strategies.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics.
- High-Precision Accuracy: Incorporates Ampio Pharmaceuticals' real-world data for credible valuation results.
- Effortless Scenario Analysis: Easily evaluate various assumptions and analyze outcomes side by side.
- Efficiency Booster: Avoid the complexities of creating detailed valuation models from the ground up.
How It Works
- 1. Access the Template: Download and open the Excel file featuring Ampio Pharmaceuticals, Inc. (AMPE) preloaded data.
- 2. Adjust Assumptions: Modify key parameters such as projected growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation scenarios.
- 5. Present with Assurance: Share professional valuation insights to bolster your decision-making process.
Why Choose This Calculator for Ampio Pharmaceuticals, Inc. (AMPE)?
- Accuracy: Utilizes real Ampio financial data to ensure precise calculations.
- Flexibility: Allows users to easily adjust and test various input parameters.
- Time-Saving: Eliminates the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
- User-Friendly: Designed for ease of use, suitable for both novice and experienced financial analysts.
Who Should Use This Product?
- Pharmaceutical Students: Discover drug development processes and apply them using real-world case studies.
- Researchers: Integrate cutting-edge models into your studies or publications.
- Investors: Evaluate your own predictions and assess valuation scenarios for Ampio Pharmaceuticals, Inc. (AMPE).
- Market Analysts: Enhance your analysis with a customizable financial model tailored for the biotech sector.
- Healthcare Entrepreneurs: Understand how public biotech companies like Ampio are evaluated and positioned in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Ampio Pharmaceuticals historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Ampio Pharmaceuticals, Inc. (AMPE).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.